STACY FLATEN: Open Payments
NPI 1063171122 · MINOT, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$217 in 11 payments from 7 companies in 2025. Trend: 2023 $303 · 2024 $429 · 2025 $217
Food & beverage: $217
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 2 | $43 |
| Lilly USA, LLC | 2 | $42 |
| ABBVIE INC. | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Lundbeck LLC | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: REXULTI, BOTOX, MOUNJARO, ARISTADA, TRINTELLIX, LYBALVI, ZEPBOUND, BREZTRI.
Industry payments across ND — which companies pay providers there.
